MINNEAPOLIS, May 23 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. today announced that the Company is scheduled to present at the FTN Midwest Securities Corp 2006 Health Care Conference on Wednesday, June 7, 2006 at 9:00am (EDT). On Thursday, June 15, 2006 at 8:30am (EDT) the company will present at the Needham 5th Annual BioTechnology & Medical Technology Conference.
Howard Root, Chief Executive Officer of Vascular Solutions, will deliver both of the Company’s presentations. To hear the live audio webcasts and view the slides of the Vascular Solutions’ presentations, go to the investor relations page of the Company’s web site http://www.vascularsolutions.com and click on the “IR Conferences” icon a few minutes prior to start time to download any necessary software.
About FTN Midwest Securities Corp
FTN Midwest, an institutional equity research firm, is a leading innovator in the investment research industry. FTN Midwest is dedicated to providing clients with unbiased and detailed analyses on domestic and multi-national companies. They focus on being a leading source for thorough and accurate investment research on companies in a variety of specialized sectors, including consumer, health care, manufacturing and industrial, technology, business and financial services.
About Needham & Company, LLC
Needham & Company, LLC is a nationally recognized investment banking and asset management firm focused primarily on serving emerging growth industries and their investors. Needham & Company’s principal activities are public and private financings; corporate finance advisory services, including mergers, acquisitions and divestitures; equity research; sales and trading primarily for institutional investors; and asset management through public and private funds.
About Vascular Solutions
Vascular Solutions, Inc. is a medical device company that focuses on developing unique solutions for unmet clinical opportunities within Interventional radiology and Interventional cardiology. New products introduced since the second half of 2003 include the Vari-Lase(R) endovenous laser product line for the treatment of varicose veins, the D-Stat Dry(TM) hemostatic bandage for the rapid control of topical bleeding, the Pronto(TM) extraction catheter for the mechanical extraction of soft thrombus, the Langston(R) dual lumen catheter for the measurement of aortic stenosis and the Twin-Pass(TM) dual access catheter for dual wire access in interventional cardiology procedures. The Company’s other major products include the Duett(TM) sealing device to rapidly seal the puncture site following catheterization procedures and the D-Stat(R) Flowable hemostat for the local management of active bleeding.
The information in this press release contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements. Important factors that may cause such differences include those discussed in our Annual Report on Form 10-K for the year ended December 31, 2005 and other recent filings with the Securities and Exchange Commission. The risks and uncertainties include, without limitation, risks associated with the need for adoption of our new products, limited working capital, lack of profitability, exposure to intellectual property claims, dependence on key vendors, exposure to possible product liability claims, the development of new products by others, doing business in international markets, limited manufacturing experience, the availability of third party reimbursement, and actions by the FDA.
For further information, connect to http://www.vascularsolutions.com .
Vascular Solutions, Inc.
CONTACT: Howard Root, CEO, or James Hennen, CFO, of Vascular Solutions,+1-763-656-4300
Web site: http://www.vascularsolutions.com/
